The psychomotor development of children is a complex parameter for their body formation and a diagnostically reliable method for assessing mental and somatic health. At present, the number of newborns is increasing, especially among premature children, who develop serious neurological problems that were initially determined by a delay in psychomotor development and were regarded as morphological and functional features of an immature child. In our country and abroad, there are various methods of eliminating the consequences of cerebral ischemia. In connection with this problem, we have treated patients with hydrotherapy and evaluated the results of the study on the Bayley scale for a comprehensive characteristic of motor and mental development. The obtained data also made a significant contribution to abilitation measures aimed at preventing cerebral ischemia consequences.
Currently, the issues of diagnosis of hypoxic-ischemic encephalopathy (cerebral ischemia) in premature newborns are relevant all over the world. The frequency of occurrence of hypoxic-ischemic encephalopathy is from 2 to 9 cases per 1000 newborns, there are negative consequences: 10–15% – fatal, 25–30% disability. The purpose of the study is to determine the clinical and neurological features of cerebral ischemia of varying severity in premature newborns using the Sarnat scale. As a result of the survey of premature newborns with cerebral ischemia, new data on the clinical and neurological status of premature children were obtained on the Sarnat classification, which can be widely used for further diagnostics and when choosing therapeutic tactics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.